HEAL Italia Foundation will take part in Italy on the Move 2026, Italy’s flagship international event dedicated to the Life Sciences ecosystem, scheduled for January 14, 2026, at INNOVIT – Italian Innovation and Culture Hub in San Francisco, during J.P. Morgan Healthcare Conference Week.
HEAL Italia Foundation will participate in the event “Italy on the Move”, scheduled to take place on 14 January 2026 in San Francisco (USA). The event is an official side event of the 44th J.P. Morgan Healthcare Conference, the most important global gathering dedicated to the healthcare and life sciences sector, which each year brings together leading international stakeholders from research, industry, and finance.
In this context, the HEAL Italia Foundation positions itself as an international hub in the field of health biotechnology, thanks to its demonstrated relevance and distinctive role in precision medicine. This positioning is further confirmed by the invitation to participate in “Italy on the Move” extended by the Italian Trade Agency (ITA), following the success of the Foundation’s recent participation in the BIO International Convention in Boston.
As part of the event program, the HEAL Italia Foundation will feature a presentation by Prof. Piacentini, who will outline the Foundation’s scientific and strategic vision, the value of translational research, and the opportunities for international collaboration in the field of health biotechnology. Materials related to the Foundation’s participation will be made available soon.
Participation in “Italy on the Move” represents a strategic opportunity for the HEAL Italia Foundation to strengthen its international positioning, consolidate its role as a key interlocutor within the global life sciences research and innovation landscape, and contribute to promoting the Italian ecosystem as a competitive and reliable environment for investments and partnerships, with particular emphasis on precision medicine.
Among the objectives of this participation is the further consolidation of international relationships, with the aim of fostering the involvement of leading foreign public and private stakeholders operating in the United States market—one of the most advanced globally in the life sciences sector.
